loading

Finanzdaten der Minerva Neurosciences Inc-Aktie (NERV)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
13.55%
3.3741
3.9029 4.5222 4.3667 6.2776
Depreciation and Amortization
0.07%
0.00136
0.00136 0.00136 0.00136 0.00136
Operating Income/Loss
13.55%
-3.3741
-3.9029 -4.5222 -4.3667 -6.2776
Income/Loss From Continuing Operations Before Tax
13.17%
-3.2586
-3.753 -4.272 22.51 -8.2335
Income/Loss From Continuing Operations After Tax
13.17%
-3.2586
-3.753 -4.272 22.51 -8.2335
Net Income/Loss
13.17%
-3.2586
-3.753 -4.272 22.51 -8.2335
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.00%
7.569
7.569 - 7.569 7.569
Diluted Average Shares
0.00%
7.569
7.569 -0.0045 7.569 7.569
Basic Earnings Per Share
14.00%
-0.43
-0.50 -0.56 2.97 -1.09
Diluted Earnings Per Share
14.00%
-0.43
-0.50 -0.56 2.97 -1.09
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$20.35
price down icon 0.88%
$81.33
price down icon 3.26%
$28.89
price down icon 1.99%
$98.30
price down icon 1.44%
$135.49
price down icon 3.95%
biotechnology ONC
$328.74
price down icon 0.34%
Kapitalisierung:     |  Volumen (24h):